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Background: Nicotinic acid (niacin) is a broad-spectrum lipid-modifying agent that has
potent antioxidant properties and reduces the production of lipid peroxidation.
Objective: The purpose of the present study was to investigate the maturation, embryo
development and cryo-tolerance merit, and levels of malondialdehyde (MDA), total
oxidant status, and total antioxidant capacity following the supplementation of bovine
oocytes maturation medium with different concentrations of niacin.
Materials and Methods: Immature cumulus-oocyte complexes were cultured in tissue
culture medium-199 maturation media supplemented with 0, 100, 200, and 400
µM niacin under a standard in vitro culture condition. After 24 hr of culture, the
nuclear maturation rate was assessed. Then, two groups of immature cumulus-oocyte
complexes were cultured in TCM-199 either with or without 400 µM niacin and
evaluated for embryo development. Also, matured cumulus-oocyte complexes in both
groups were frozen using a standard vitrification procedure. After vitrification, oocytes
were warmed in two steps and evaluated for embryo development. In addition, the
level of total antioxidant capacity, total oxidant status, and MDA were measured.
Results: The results indicated that although the treatment with 400 µM niacin increased
in vitro nuclear maturation (87.6 ± 5.3), it did not improved the embryo development to
the blastocyst stage. Higher cleavage and blastocyst rates were observed in vitrified
oocytes that were cultured with supplemented 400 µM niacin compared to the control
group (without niacin) (53.6 ± 2.7 and 10.6 ± 1.6 vs. 46.2 ± 4.1 and 6.3 ± 2.4, respectively).
Also, the addition of 400 µM niacin to the maturation media could decrease MDA levels
after maturation.
Conclusion: Niacin could improve the quality of in vitro embryo production (IVP)
embryos and tolerance of bovine oocytes to vitrification.
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1. Introduction
In recent decades, successful reproductive
technologies have been developed in farm animals.
One of the benefits of in vitro embryo production
(IVP) is generating large numbers of embryos at low
costs. However, the IVP embryos have lower quality
than those produced in vivo. Therefore, to optimize
IVP outcome acquiring the necessary factors for
bovine oocyte metabolism is essential. The first
and most critical step in the achievement of IVP
is maturation of oocyte in vitro. Culture condition is
one of the major factors influencing the efficiency
of IVM. Under the in vitro atmospheric oxygen
tension (20% O2), a high concentration of reactive
oxygen species (ROS) is generated that could
joint to cellular macromolecules such as lipids and
promote lipid peroxidation (LPO), resulting in cell
damage (1). Therefore, reducing ROS in germ cells
by antioxidants could improve their developmental
merit. The deficiency of antioxidant capacity within
follicle has shown to decrease the maturation
competency of the oocyte and, therefore, interfere
in the process of fertilization and development
(2, 3). Enzymatic antioxidants such as catalase
(CAT), superoxide dismutase (SOD), and the level
of non-enzymatic antioxidants including L-carnitine,
cysteamine, cysteine, and N-acetyl-L-cysteine, have
been used to solve this problem (4, 5). “Nicotinic
acid (niacin) is a lipid-modifying agent that
decreases plasma triglyceride and low-density
lipoprotein while raising high-density lipoproteins”
(6). Also, pieces of evidence from studies supported
that Nicotinamide (NA) has potent antioxidant
properties and its deficiency increases oxidative
stress (7, 8). These studies showed that niacin status
could affect the stir of several antioxidant enzymes
such as SOD, CAT, and Glutathione Reductase.
Furthermore, niacin could reduce the generation
of LPO biomarkers such as malondialdehyde
(MDA) in rats (8, 9). Also, it has been shown
that the addition of niacin to embryo culture
in the condition of heat shock could relatively
improve embryo development to the blastocyst
stage (10).
To our knowledge, no study has reported
the effect of niacin supplementation to IVM
medium on nuclear maturation, developmental
competence, and cryo-tolerance in bovine oocytes.
We hypothesized that niacin could improve the
quality of IVP embryos and cryo-tolerance of bovine
oocytes, either by antioxidant activity or by reducing
LPO. Therefore, the present study was designed
to evaluate the effects of niacin addition during
IVM on nuclear maturation and cryo-tolerance
after vitrification in the bovine oocyte. In addition,
the level of total antioxidant capacity (TAC),
total oxidant status (TOS), and MDA were
measured.
2. Materials and Methods
All chemicals were purchased from Sigma
(St. Louis, MO, USA) unless otherwise indicated.
2.1. Experimental design
This experimental study was carried out in the
IVF Laboratory at the School of Veterinary Medicine,
Shiraz, Iran, between September and October
2017.
Experiment 1: In vitro maturation of bovine
oocytes was performed in the presence of niacin at
different concentrations (0, 100, 200, and 400 µM).
At the end of maturation, cumulus cell expansion
and nuclear maturation rates were determined.
Experiment 2: Based on the results of
experiment 1, 400 µM concentration were used to
investigate the effects of niacin supplementation in
IVM medium on their subsequent developmental
competence and cryopreservation. In vitro matured
oocytes in the presence of niacin (0 and 400 µM)
were vitrified. Next, they were thawed after a week.
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Vitrified and nonvitrified oocytes were fertilized and
then cultured for eight days. Cleavage, morula, and
blastocyst rates were determined on days 2, 6,
and 8 of in vitro culture, respectively. For further
investigation, the levels of TAC, TOS, and MDA
were measured in immature oocytes, which were
matured in 400-µM niacin and matured without
niacin (control group).
2.2. Oocyte recovery
Cattle ovaries were collected from the Shiraz
abattoir and transported to the laboratory in
normal saline solution at 35 ◦C, within 3 hr. The
cumulus-oocyte complexes (COCs) were recovered
from healthy follicles (2–8 mm follicles) with a 20G
needle. Excellent and good quality oocytes were
selected for IVM (11).
Experiment 1: Effects of niacin addition in IVM
medium on oocyte nuclear maturation
To determine the effects of niacin on nuclear
maturation, a total of 676 good or excellent quality
COCs were randomly assigned to four groups:
control (CG, n = 142) without niacin, treated with
niacin 100 µM (N100, n = 157), niacin 200 µM (N200,
n = 188), and niacin 400 µM (N400, n = 189). In
all the selected experimental groups, the COCs
were washed in washing medium (HEPES-buffered
TCM-199 supplemented with 10% fetal calf serum
(FCS)) and cultured in IVM medium (TCM-199
supplemented with 10% heat-treated FCS), and with
0.1 IU/mL recombinant human FSH (Follitrope, LG
Life Sciences, South Korea), 5 IU/mL highly purified
hCG (Karma, Pharmatech GmbH, Germany), and
50 µg/ml gentamicin supplemented with niacin at
0, 100, 200, and 400 µM (control, N100, N200
and N400 groups, respectively). Groups of 30–40
COCs were incubated in 500 µl equilibrated
maturation medium in four-well culture dishes
(NuncTM, Denmark) for 24 hr at 38.5 ◦C in 5% CO2
at 90% humidified atmosphere. The experiment was
performed in five replicates (12).
2.3. Evaluation of nuclear maturation
of oocytes
After maturation, the degree of cumulus
expansion was scored under a stereo zoom
microscope based on a subjective scale of 0 to
2, where 0 indicates no detectable expansion
and 2 indicates full expansion. To evaluate
meiotic progression, the oocytes were denuded by
frequent pipetting, mounted on glass microscope
slides under coverslips and fixed for at least
24 hr with acetic alcohol (1:3) and then stained
with 1% aceto-orcein (1% orcein in 45% glacial
acetic acid) and examined for nuclear morphology
with a compound microscope at ×100 and
×400 magnifications. “Oocytes were classified
as follows: immature (did not reach metaphase),
mature (presented a metaphase II plate and
the polar body), and abnormal (any chromosomal
aberrations such as diploid, abnormal metaphase
II, multidirectional spindle, and chromosomal
dispersion)” (13).
Experiment 2: Effects of niacin addition in
IVM medium on cryotolerance and subsequent
embryonic development
To evaluate the effects of niacin on cleavage rate
and embryo development, a total of 677 oocytes
were divided into four groups: (1) culture in IVM
medium that was not vitrified (CG, n = 182); (2)
culture in IVM medium with 400 µM niacin that
was not vitrified (CN, n = 177); (3) culture in IVM
medium that was vitrified (CV, n = 158); and (4)
culture in IVM medium with 400 µM niacin that
was vitrified (NV, n = 160). Following maturation,
oocytes were transferred into 500µl of fertilization
medium (modified Tyrode’s medium) in four-well
dishes (NuncTM, Denmark) (50 COCs/well). Frozen
semen that was previously tested in the lab was
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used for fertilization. Motile spermatozoa were
acquired by the swim-up method and were added to
wells containing oocytes at a final concentration of
106 spermatozoa ml−1. Oocytes and spermatozoa
were incubated together for 24 hr at 38.5 ◦C in
5% CO2 under maximum relative humidity. At the
end of the fertilization period, presumptive zygotes
were completely denuded by repeated pipetting
and transferred into the culture medium (modified
synthetic oviduct fluid (mSOF) supplemented with 4
mg/ml fatty acid-free BSA) and cultured in four-well
dishes at 38.5 ◦C for eight days of 5% CO2 under
maximum relative humidity. The embryo culture
medium was renewed every 48 hr. Fertilization day
was considered as day 0. Embryonic cleavage,
morula, and blastocyst rates were determined on
days 2, 6, and 8 of in vitro culture, respectively
(13, 14). This experiment was performed in five
separate replicates.
2.4. Vitrification and warming of
matured oocytes
After IVM, COCs were partially denuded in the
presence of 1 mg/ml hyaluronidase for 1 min. A
group of 3–5 oocytes was placed in equilibration
solution (7.5% dimethylsulfoxide (DMSO) and 7.5%
ethylene glycol (EG) in holding medium (HM;
TCM-199-HEPES+20% FBS)) for 9 min and then
transferred to vitrification solution (15% DMSO, 15%
EG, and 0.5 mol/L sucrose in HM) for 45 sec
at 25 ◦C. Oocytes were loaded onto the tip of
Cryotop (Kitazato Supply Co., Tokyo, Japan) in a
small volume of vitrification solution and plugged
into liquid nitrogen immediately. Warming of vitrified
oocytes was done by immersing the Cryotop tip
directly in a 37 ◦C warming solution composed
of HM and 1 M sucrose for 1 min, followed by
treatment with HM supplemented with 0.5 M for
3 min (15). Afterward, the retrieved oocytes were
washed and transferred to HM until the next
procedure.
2.5. Measurement of MDA, TAC, and
TOS in oocytes
To determine the effects of niacin on the
levels of MDA, TAC, and TOS following maturation,
50 expanded COCs were collected from each
experimental group (i.e., immature oocytes, control
mature oocytes without niacin, and oocytes
matured with niacin) and washed three times in
phosphate-buffered saline (PBS). A number of 50
oocytes in 50 µl of PBS were frozen at −20 ◦C
until use. After repeated freeze-thaw cycles for lysis
of cells, the levels of mentioned parameters were
measured in all groups with specific kits (ZellBio
GmbH, Germany) according to the manufacturer’s
instructions.
2.6. Ethical consideration
This study was approved by the ethical working
with animals and research committee of the
School of the Veterinary Medicine, Shiraz University
(94GCU6M1251).
2.7. Statistical analysis
One-way analysis of variance (ANOVA) and post
Tukey test were used for comparing expansion
of cumulus cells, oocyte maturation, embryo
development (cleavage and blastocyst rate), and
the levels of MDA, TOS, and TAC among
experimental groups (significance at p < 0.05).
All statistical analyses were performed using
a computer-aided statistical software package
(IBM R©SPSS Statistics version 22 for windows). Also,
all data are presented as mean ± SD.
3. Results
3.1. Effects of niacin addition in IVM
medium on nuclear maturation
After in vitro oocyte maturation, no difference
was observed in the mean percentage of partially
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and fully expanded COCs among groups (Table I).
In the present study, the supplementation of IVM
medium with niacin improved nuclear maturation of
oocytes (Table II). The highest nuclear maturation
rates were acquired in the N400 group (87.6 ±
5.3%) which was significantly higher than that in
the control group (78.1 ± 3.7), N100 (75.7 ± 5.1)
and N200 (76.5 ± 5.2) (p = 0.03, p < 0.001, and
p = 0.01, respectively). No significant difference
was observed in nuclear maturation between other
groups (Table II).
3.2. Effects of niacin addition in
IVM medium on embryonic
developmental competence of
non-vitrified and vitrified IVM
oocytes
Following IVF and IVC, no difference was
observed in cleavage and embryo development
between non-vitrified control and N400 groups
(Table III). As shown in Table IV, in the vitrified
groups, the cleavage rate, blastocyst formation, and
cleaved/blast rate were significantly higher in the
niacin vitrified (NV) group than the control vitrified
(CV) group (p < 0.001) (53.6 ± 2.7, 10.6 ± 1.6 and
19.9 ± 3.2 vs. 46.2 ± 4.1, 6.3 ± 2.4 and 13.6 ± 4.4,
respectively).
3.3. Effects of niacin supplementation
in IVM medium on the levels of
MDA, TAC, and TOS
The level of MDA in the immature group was
significantly higher than the control mature and
niacin mature groups (p = 0.04 and p = 0.02,
respectively). In addition, the level of MDA in niacin
mature group was significantly lower than the other
groups (Figure 1). No difference was observed in
the levels of TAC (0.07, 0.08, and 0.08 mmol/50 for
immature COCs, mature COCs, and mature COCs
in niacin group, respectively) and TOS (6.8 ± 0.3,
6.7 ± 0.4, and 6.8 ± 0.3 µmol/50 for immature
COCs, mature COCs, and mature COCs in
niacin group, respectively) among experimental
groups.
Table I. Mean ( ± SD) percentages of cumulus cell expansion following the addition of niacin at different concentration to the
maturation media
Group N Grade 2 Grade 1 Grade 0
Control 152 114 (76.06 ± 6.9) 33 (21.03 ± 5.8) 6 (3.3 ± 3.2)
N100 120 90 (75.4 ± 4.8) 22 (18.6 ± 1.9) 8 (5.9 ± 5.1)
N200 117 82 (71.5 ± 8.1) 34 (27.3 ± 14.8) 10 (8.09 ± 1.7)
N400 190 143 (72.4 ± 15.1) 34 (20.3 ± 11.9) 13 (7.2 ± 4.9)
Data presented as n (%)
Grade 2, full expansion; Grade 1, partial expansion; Grade 0, no expansion
Table II. Mean ( ± SD) percentages of nuclear maturation following the addition of niacin to the maturation media
Group N Mature Immature Abnormal
Control 142 110 (78.1 ± 3.7) 22 (16.2 ± 4.1) 10 (5.6 ± 6.5)
N100 157 119 (75.7 ± 5.0) 26 (15.5 ± 7.4) 12 (8.7 ± 8.1)
N200 188 144 (76.5 ± 5.2) 27 (13.9 ± 4.4) 17 (9.6 ± 5.9)
N400 189 167 (87.6 ± 5.3)∗ 8 (4.3 ± 1.7)∗ 14 (7.9 ± 5.5)
Data presented as n (%)
The N100, N200 and N400 have treated groups with 100, 200, and 400 µM of niacin, respectively
* Represents a significant difference between N400 and other groups at P < 0.05 level; data were compared by One-Way Analysis
of Variance (ANOVA) and post Tukey’s test
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Table III. Mean ( ± SD) percentages of cleavage, morula, and blastocyst yield following in vitro maturation of oocytes in addition of
400 µM niacin
Group N Cleaved∗ Morula∗ Blastocyst∗ Blast/cleaved∗∗
CG 182 137 (75.3 ± 1.1) 74 (40.6 ± 3.4) 39 (21.5 ± 1.4) 28.6 ± 1.8
CN 177 135 (76.3 ± 0.8) 74 (41.7 ± 3.3) 36 (20.2 ± 2.4) 26.5 ± 3.2
* Data presented as n (%); ∗∗Data presented as %
CG, culture in IVM medium and not vitrified; CN, culture in IVM medium with 400 µM niacin and not vitrified. Comparisons among
groups were performed using One-Way ANOVA and no significant difference was observed between groups
Table IV. Mean ( ± SD) percentages of cleavage, morula, and blastocyst yield following vitrification of mature oocytes in addition
to 400 µM niacin
Group N Cleaved∗∗ Morula∗∗ Blastocyst∗∗ Blast/cleaved∗
CV 158 73 (46.2 ± 4.1) 37 (23.2 ± 3.4) 10 (6.3 ± 2.4) 13.6 ± 4.4
NV 160 86 (53.6 ± 2.7)# 41 (25.6 ± 2.4) 17 (10.6 ± 1.6)# 19.9 ± 3.2#
* Data presented as n (%); ∗∗Data presented as %
CV: control vitrified oocytes group; NV: niacin vitrified oocytes group
#Represents a significant difference between CV and NV group at p < 0.001 level. Data were compared by One-Way Analysis of



































Figure 1. The level of MDA in all groups (mean ± SD); a, b,
and c represent a significant difference between groups at
p < 0.05 level.
4. Discussion
This experimental study is the first to show
that addition of niacin (400 um) could positively
affect nuclear maturation and blastocyst yield of
vitrified bovine oocytes. Nuclear maturation of
oocytes is one of the critical steps in the success
of IVP. The results showed that niacin treatment
with 400 µm concentration during IVM could
increase nuclear maturation rates and improve
the developmental ability to the blastocyst stage
of vitrified oocytes. The oxygen concentration in
culture (in vitro) is higher than that in an in vivo
environment, leading to an increased level of ROS
(1). Therefore, the antioxidant effect of niacin may
be a principal factor for the improved development
in the niacin-supplemented group. In addition,
niacin is a lipid-modifying agent that decreases
plasma triglyceride. It may reduce the intracellular
lipid content in oocytes and, consequently,
improve tolerance to cryo-damage. However,
further investigations are needed to clarify the
exact cellular processes of niacin treatment during
oocyte maturation. Similar to niacin, treatment
of IVM medium with L-carnitine with antioxidant
activity has improved embryo developmental
merit of IVM oocytes after freezing (16). Since
vitrification increases ROS in vitro, oxidative stress
causes damage to macromolecules, including
lipids, proteins, carbohydrates, and DNA in all
cells of mammals (17). High ROS concentrations
have harmful effects on germ cells and embryos.
Oxidation of unsaturated fatty acids is one of
the most important harmful effects of LPO. MDA
is one of the end stable products of LPO that
can be used as a cumulative measure of LPO
(18, 19). MDA levels are also used as a marker in
predicting the outcomes of assisted reproductive
techniques (ART). It has been shown that there
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is a relationship between the levels of MDA
in follicular fluid and cleavage rates in women
treated in ARTs. The high levels of MDA indicated
a negative correlation with fertilization rate and
a negative influence on embryonic development
competence (20, 21). In the present study, the level
of MDA was reduced significantly in niacin-treated
group compared to the other groups. In several
animal studies, it has been shown that niacin
deficiency could adversely affect LPO and niacin
administration could decrease the production of
LPO biomarkers (8, 9, 22). It has been proved
that TAC of ovarian follicular fluid has a positive
relation with oocyte maturation rate and can serve
as a predictive marker of human IVF success.
Chattopadhayay and colleagues suggested that the
TAC level in follicular fluid of immature oocytes
would be lower compared to the mature oocyte in
polycystic ovarian syndrome (PCOS) patients (23).
Also, Oyawoye and colleagues have shown that a
higher TAC level increases fertilization potential in
women undergoing IVF (24). Several studies have
indicated that niacin could increase the level of
glutathione and the activity of several antioxidant
enzymes such as SOD, CAT, and GPx (8, 22).
Although in our study, the nuclear maturation
of oocytes in niacin-treated group was increased
significantly, the levels of TAC and TOS did
not change. In comparison, the level of MDA
significantly decreased in niacin-treated group
compared to the other groups. In the study of
Pasqualotto and colleagues, no association of TAC
level, oocyte maturity, fertilization, and cleavage
was reported with embryo quality (2). It seems that
MDA is better than TAC as an oxidative stress
marker, which has also been proven in the study
of Agarwal and colleagues (25). In this regard, the
niacin receptor was identified on adipose tissue by
Tunaru and colleagues (26).
According to relevant reports, many of the
beneficial and adverse effects of niacin are
mediated via a G protein receptor, GPR109A
(27, 28). Also, the GPR109A receptor was detected
in bovine oocytes and preimplantation embryos (10).
In recent years, it has been reported that niacin can
alter the expression of several genes in different
tissues (29). The activation of GPR109A can inhibit
the activity of adenylatecyclase that resulted in the
reduction of cAMP. “The decrease in the level of
cAMP in cells could affect the cAMP targets such
as protein kinase A (PKA) and exchange protein
activated by cAMP (Epac). It is known that PKA and
Epac as two factors are involved in the expression
of several genes” (30).
Therefore, in our study, the beneficial effects of
niacin in maturation medium could be mediated
also via the GPR109A receptor and the effect on
gene expression; however, further investigations
are needed to clarify this subject.
5. Conclusion
Overall, our findings support the hypothesis that
niacin in 400 µm concentration could improve
the maturation and tolerance of bovine oocytes to
vitrification by reducing LPO.
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